I haven't understood why investors are still selling 4DX when the price has stabilised in last few weeks and its potential to grow exponentially is inching as every day passes. In my opinion it is an absolute buy below the IPO issue price ($0.73) when the technology have achieved ground-breaking result in diagnosis of bronchitis, It is matter of time how this achievement will be commercialise either via partnership with global leaders or via Take Over.
Research, page-950
-
- There are more pages in this discussion • 1,916 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.5¢ |
Change
-0.020(4.60%) |
Mkt cap ! $170.3M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 43.5¢ | 41.5¢ | $48.61K | 115.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 44047 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 6200 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |